Join
Live feed
·
INSIDERFilingvia Quantisnow
Adagio Therapeutics Inc. logo

SEC Form 4: Adimab, Llc disposed of 1,158,089 shares, decreasing direct ownership by 4% to 26,687,906 units

ByQuantisnow·Wall Street's wire, on your screen.
ADGI· Adagio Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADGI (Adagio Therapeutics Inc.) and more on Quantisnow.